| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Oral elemental iron (ferrous sulphate, fumarate, gluconate, polymaltose)[1] | Iron salt | Established IDA: 100–200 mg elemental iron PO daily (or alternate-day for tolerance); empty stomach with vitamin C; reassess Hb in 2–4 weeks | Adolescent pregnancies: 60–120 mg elemental iron daily | First-line for mild–moderate IDA; nausea, constipation common — alternate-day dosing improves absorption per hepcidin physiology; iron polymaltose has fewer GI side effects |
| Intravenous iron sucrose[1] | Parenteral iron | 200 mg IV per session × 5–10 doses to total dose calculated by Ganzoni formula (iron deficit + 500 mg replenishment) | — | Indications: oral iron intolerance or non-response, severe anaemia (Hb <90 g/L), malabsorption; widely available in Indian programmes; multiple sessions required |
| Ferric carboxymaltose (alternative IV iron)[1] | Parenteral iron | 1000 mg IV single dose; can repeat once 7 days later if total dose >1000 mg required (max 2000 mg) | — | Single-dose convenience; faster repletion than iron sucrose; monitor for hypophosphataemia and hypersensitivity; avoid first trimester |
Universal supplementation, screening, and treatment of iron deficiency anaemia in pregnancy under the ICMR/MoHFW Anaemia Mukt Bharat framework.